Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021 · cited 10×

A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C

Wai, C.-T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeevaram, H. S., & Lok, A. S.-F. (2003) · Hepatology · doi:10.1053/jhep.2003.50346 · Cited by 4,406

The NAFLD fibrosis score

Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,244

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287

Liver Biopsy

Bravo, A. A., Sheth, S. G., & Chopra, S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440706 · Cited by 2,047

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.006 · Cited by 1,875

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,805

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748

LECT2, A Novel and Direct Biomarker of Liver Fibrosis in Patients With CHB

Xu, H., Li, X., Wu, Z., Zhao, L., Shen, J., Liu, J., Qin, J., Shen, Y., Ke, J., Wei, Y., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.749648 · Cited by 15

Imaging-Based Assessment of Steatosis, Inflammation and Fibrosis in NAFLD

Hardy, T., & McPherson, S. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0368-4 · Cited by 15

Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]

Bernstein, D., & Kovalic, A. J. (2022) · Metabolism Open · doi:10.1016/j.metop.2021.100158 · Cited by 17

The Value of Clinical Decision Support in Healthcare: A Focus on Screening and Early Detection

Schäfer, H., Lajmi, N., Valente, P., Pedrioli, A., Cigoianu, D., Hoehne, B., Schenk, M., Guo, C., Singhrao, R., Gmuer, D., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15050648 · Cited by 17

The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients

Wernberg, C. W., Ravnskjær, K., Lauridsen, M. M., & Thiele, M. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10050930 · Cited by 15

A sequential approach using the age‐adjusted fibrosis‐4 index and vibration‐controlled transient elastography to detect advanced fibrosis in Korean patients with non‐alcoholic fatty liver disease

Lee, D. H., Sung, S. U., Lee, Y. K., Lim, I. H., Jang, H., Joo, S. K., Park, J. H., Chang, M. S., So, Y. H., & Kim, W. K. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16766 · Cited by 14

Non-invasive assessment of metabolic dysfunction–associated fatty liver disease

Kumar, C. V. C., Skantha, R., & Chan, W. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221139614 · Cited by 14

A Pragmatic Management Approach for Metabolic Dysfunction-Associated Steatosis and Steatohepatitis

Shah, N., & Sanyal, A. J. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003215 · Cited by 15

Liver Stiffness Measurement Can Reflect the Active Liver Necroinflammation in Population with Chronic Liver Disease: A Real-world Evidence Study

Wang, L., Zhu, M., Cao, L., Yao, M., Lu, Y., Wen, X., Zhang, Y., Ning, J., Long, H., Zhu, Y., et al. (2019) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2019.00040 · Cited by 14

Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners

Canivet, C. M., Smati, S., Lannes, A., Brisseau, J., Judon, L., Roch, M. L., Cariou, B., Bellanger, W., Guerci, B., & Boursier, J. (2021) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2021.101848 · Cited by 14

Performance of Imaging Techniques in Non-invasive Diagnosis of Non-alcoholic Fatty Liver Disease in Children: A Systematic Review and Meta-Analysis

Yu, Q., Liu, Y., Hu, P., Gao, F., & Huang, G. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.837116 · Cited by 15

Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis

Cuomo, G., Iandoli, C., Galiero, R., Caturano, A., Vico, C. D., Perretta, D., Adamo, P. V., Ferrara, R., Rinaldi, L., Romano, C. P., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13101766 · Cited by 15

Liver fibrosis diagnosis support using the Dempster–Shafer theory extended for fuzzy focal elements

Porębski, S., Porwik, P., Straszecka, E., & Orczyk, T. (2018) · Engineering Applications of Artificial Intelligence · doi:10.1016/j.engappai.2018.09.004 · Cited by 13

Noninvasive diagnosis in alcohol‐related liver disease

Hadefi, A., Degré, D., Trépo, E., & Moreno, C. (2020) · Health Science Reports · doi:10.1002/hsr2.146 · Cited by 12

Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study

Chen, Z.-W., Tang, K., Zhao, Y., Chen, Y.-Z., Tang, L., Li, G., Huang, O., Wang, X., Targher, G., Byrne, C. D., et al. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.64458 · Cited by 13

Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care

Caballería, L., Augustín, S., Broquetas, T., Morillas, R. M., Vergara, M., Virolés, S., Hernández, M. R., Serra, I., Goday, A., Vila, L., et al. (2019) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2019.06.010 · Cited by 13

New onset non‐alcoholic fatty liver disease after resection of pancreatic neuroendocrine tumors

Mackay, T. M., Genc, C., Takkenberg, R. B., Besselink, M. G., Somers, I., & van Dijkum, E. J. M. N. (2018) · Journal of Surgical Oncology · doi:10.1002/jso.25051 · Cited by 12

Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease

Vos, M. B., Dimick‐Santos, L., Mehta, R., Omokaro, S. O., Taminiau, J. A. J. M., Schabel, E., Kleiner, D. E., Szitányi, P., Socha, P., Schwimmer, J. B., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.08.048 · Cited by 12

Relationship between Dietary Fatty Acid Intake with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in People with HIV

de Almeida, C. F., da Silva, P. S., Cardoso, C. S. D. A., Gorni, N., Cormack, J. A., de Andrade, M. M., Silva, J. D. S., Araújo, M. C., Peres, W. A. F., do Brasil, P. E. A. A., et al. (2021) · Nutrients · doi:10.3390/nu13103462 · Cited by 12

Emerging new standard for non-invasive assessment of liver disease mortality in non-alcoholic fatty liver disease

Loo, S., & Chan, W. (2017) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2017.03.06 · Cited by 12

Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes

Poynard, T., Peta, V., Deckmyn, O., Pais, R., Ngo, Y., Charlotte, F., Ngo, A., Munteanu, M., Imbert‐Bismut, F., Monneret, D., et al. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001606 · Cited by 12

Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLD

Pons, M., Rivera‐Esteban, J., Manzano-Núñez, R., Bañares, J., Bermúdez, M., Vargas, V., Salcedo, M. T., Castells, L., Augustín, S., Mínguez, B., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092466 · Cited by 13

Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?

Morrison, M., Hughes, H., Naggie, S., & Syn, W. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05861-7 · Cited by 11

Magnetic Resonance imaging analysis of liver fibrosis and inflammation: overwhelming gray zones restrict clinical use

Aguado, D. M., Rodríguez, A., Alberich‐Bayarri, Á., & Martí‐Bonmatí, L. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02713-1 · Cited by 11

Pediatric Nonalcoholic Fatty Liver Disease

Mitsinikos, T., Mrowczynski-Hernandez, P., & Kohli, R. (2021) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2021.07.013 · Cited by 11

Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study

Thévenot, T., Vendeville, S., Weil, D., Akkouche, L., Calame, P., Canivet, C. M., Vanlemmens, C., Richou, C., Cervoni, J., Seronde, M., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266965 · Cited by 11

Factors predictive of the efficacy of bezafibrate therapy in patients with primary sclerosing cholangitis

Mizuno, S., Isayama, H., Hirano, K., Watanabe, T., Takahara, N., Kogure, H., Matsubara, S., Nakai, Y., Tada, M., & Koike, K. (2016) · Hepatology Research · doi:10.1111/hepr.12846 · Cited by 11

Prevalence of Nonalcoholic Steatohepatitis and Associated Fibrosis Stages Among US Adults Using Imaging-Based vs Biomarker-Based Noninvasive Tests

Fishman, J., O'Connell, T., Parrinello, C. M., Woolley, J. J., Bercaw, E., & Charlton, M. (2024) · Journal of health economics and outcomes research · doi:10.36469/jheor.2024.92223 · Cited by 10

Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD

Hegmar, H., Wiggers, T., Nasr, P., Vessby, J., Kechagias, S., Nyhlin, N., Marschall, H., Borssén, Å. D., Strandberg, R., Karsdal, M. A., et al. (2024) · Journal of Internal Medicine · doi:10.1111/joim.13813 · Cited by 10

FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Dallio, M., Romeo, M., Nardo, F. D., Vaia, P., Napolitano, C., Ventriglia, L., Coppola, A., Silvestrin, A., Olivieri, S., & Federico, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020761 · Cited by 10

Clinical and laboratory associations of liver fibrosis indexes in patients with decompensated Chronic Heart Failure II-IV Functional Classes

Stolbova, S. K., Dragomiretskaya, N. A., Beliaev, Y. G., & Podzolkov, V. I. (2020) · Kardiologiia · doi:10.18087/cardio.2020.5.n920 · Cited by 10

Nonalcoholic fatty liver disease: use of diagnostic biomarkers and modalities in clinical practice

Alqahtani, S. A., & Schattenberg, J. M. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1964958 · Cited by 10

A single blood test adjusted for different liver fibrosis targets improves fibrosis staging and especially cirrhosis diagnosis

Calès, P., Boursier, J., Oberti, F., Moal, V., Hubert, I. F., Bertrais, S., Hunault, G., Rousselet, M. C., & multicentric groups (SNIFF, A. H. 2. (2018) · Hepatology Communications · doi:10.1002/hep4.1161 · Cited by 10

A noninvasive indicator for the diagnosis of early hepatitis B virus-related liver fibrosis

Li, B., Zhang, L., Zhang, Z., Yan, G., Zhu, L., Lu, W., & Yu, H. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001281 · Cited by 10

The Role of Radiologic Modalities in Diagnosing Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Weiskirchen, R., & Tacke, F. (2018) · Current Hepatology Reports · doi:10.1007/s11901-018-0421-y · Cited by 9

Serum biomarkers for liver fibrosis assessment

Maroto‐García, J., Álvarez, A. M., de Pedro, M. P. S., Soto, A. B., & González, Á. (2023) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2023-0081 · Cited by 12

Simple blood fibrosis tests reduce unnecessary referrals for specialized evaluations of liver fibrosis in NAFLD and ALD patients

Broussier, T., Lannes, A., Zuberbuhler, F., Oberti, F., Fouchard, I., Hunault, G., Calès, P., & Boursier, J. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.07.010 · Cited by 9

The diagnostic conundrum in non-alcoholic fatty liver disease

Rosato, V., Masarone, M., Aglitti, A., & Persico, M. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00018 · Cited by 9

Elastographic liver evaluation of Katukyadi churna in the management of Non-Alcoholic Steatohepatitis (NASH) – A single arm clinical trial.

Tarapure, S., Tubaki, B. R., & Khot, S. (2021) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2020.12.015 · Cited by 9

Ability of a Combined FIB4/miRNA181a Score to Predict Significant Liver Fibrosis in NAFLD Patients

Lima, R. V. C., Stefano, J. T., Malta, F. D. M., Pinho, J. R. R., Carrilho, F. J., Arrese, M. A., & de Oliveira, C. P. M. S. (2021) · Biomedicines · doi:10.3390/biomedicines9121751 · Cited by 9

The future R&D landscape in non-alcoholic steatohepatitis (NASH)

Black, D., Brockbank, S., Cruwys, S., Goldenstein, K., Hein, P., & Humphries, B. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.09.020 · Cited by 9

Hepatitis Delta and Liver Disease Among People Living With Hepatitis B With or Without HIV Co‐Infection in Senegal

Wembulua, B. S., Gal, F. L., Ndiaye, O., Pandi, M. S., Akotia, M. K., Badiane, A. S., Hamouda, P., Tine, J. M., Ndiaye, K., Béguelin, C., et al. (2025) · Liver International · doi:10.1111/liv.70026 · Cited by 8

Liver Stiffness Is a Predictor of Rebleeding in Patients With Hepatitis B-Related Cirrhosis: A Real-World Cohort Study

Liu, L., Nie, Y., Zhang, Y., Liu, Q., & Zhu, X. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.690825 · Cited by 8

Noninvasive tests in the evaluation of nonalcoholic fatty liver disease: A review

Tun, K. M., Noureddin, N., & Noureddin, M. (2023) · Clinical Liver Disease · doi:10.1097/cld.0000000000000066 · Cited by 8

How to Identify the Patient with Nonalcoholic Steatohepatitis Who Will Progress to Cirrhosis

Henry, Z. H., & Argo, C. K. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.09.002 · Cited by 8

A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease

Kosick, H. M.-K., Keyrouz, A., Adeyi, O. A., Sebastiani, G., & Patel, K. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06748-8 · Cited by 8

Use of finger‐piece method for indocyanine green clearance test

Sagawa, E., Okubo, H., Sorin, Y., Nakadera, E., Fukada, H., Igusa, Y., Kokubu, S., Miyazaki, A., Watanobe, I., Sugo, H., et al. (2016) · Hepatology Research · doi:10.1111/hepr.12858 · Cited by 8

Development and Validation of Machine Learning‐Based Marker for Early Detection and Prognosis Stratification of Nonalcoholic Fatty Liver Disease

Xiao, L., Zeng, L., Wang, J., Hong, C., Zhang, Z., Wu, C., Cui, H., Li, Y., Li, R., Liang, S., et al. (2025) · Advanced Science · doi:10.1002/advs.202410527 · Cited by 7

European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) steatotic liver disease special interest group position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction‐associated steatotic liver disease

Mann, J. P., Lefere, S., Buytaert, M., Alisi, A., Arikan, C., Brecelj, J., Brown, R. M., Degrassi, I., Fiore, G., Fitzpatrick, E., et al. (2026) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70490 · Cited by 9

Development and validation of a non-invasive model for predicting significant fibrosis based on patients with nonalcoholic fatty liver disease in the United States

Guo, Y., Shen, B., Xue, Y., & Li, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1207365 · Cited by 7

FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease

Arvaniti, P. (2023) · Annals of Gastroenterology · doi:10.20524/aog.2023.0841 · Cited by 7

Non-invasive diagnosis of patients with ‘at-risk’ NAFLD : only fibrosis counts?

Geier, A., & Boursier, J. (2020) · Gut · doi:10.1136/gutjnl-2020-320785 · Cited by 7

Transient elastography with controlled attenuation parameter (CAP) for diagnosis of moderate or severe steatosis in people with suspected non-alcoholic fatty liver disease

Turankova, T. A., Blyuss, O. B., Brazhnikov, A. Y., Svistunov, A. А., Gurusamy, K. S., & Pavlov, C. S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013670 · Cited by 10

A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis B

Chen, Y., Gong, J., Zhou, W., Jie, Y., Li, Z., Chong, Y., & Hu, B. (2020) · BioMed Research International · doi:10.1155/2020/6839137 · Cited by 7

Plasma Levels of Homocysteine is Associated with Liver Fibrosis in Health Check-Up Population

Lv, D., Wang, Z., Ji, S., Wang, X., & Hou, H. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s329863 · Cited by 7

Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes

Gracen, L., Hayward, K. L., Aikebuse, M., Russell, A. W., O’Beirne, J. P., McPhail, S., Irvine, K. M., Williams, S., Valery, P. C., & Powell, E. E. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07808-7 · Cited by 7

Noninvasive Risk Stratification for Nonalcoholic Fatty Liver Disease Among Living Liver Donor Candidates: A Proposed Algorithm

Danış, N., Weeks, S. R., Kim, A., Baghdadi, A., Ghadimi, M., Kamel, I. R., Saberi, B., Woreta, T. A., Garonzik‐Wang, J., Philosophe, B., et al. (2021) · Liver Transplantation · doi:10.1002/lt.26365 · Cited by 7

Non-alcoholic fatty liver disease: beyond the liver is an emerging multifaceted systemic disease

Adinolfi, L. E., Marrone, A., & Rinaldi, L. (2018) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2018.02.01 · Cited by 7

Taming fatty liver: can taurine combat metabolic dysfunction in MASLD?

Meng, L., Lu, F., Zhang, B., Ma, Y., & Gao, J. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02439-x · Cited by 6

Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver Disease

De, A., Chalasani, N., & Duseja, A. K. (2025) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2025.09.003 · Cited by 6

Screening patients in general practice for advanced chronic liver disease using an innovative IT solution: The Liver Toolkit

Prince, D. S., Hoque, S., Kim, C., Maher, S., Miller, J., Chomley, P., Pritchard‐Jones, J., Spruce, S., McGarry, N., Baker, D., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000482 · Cited by 6

Cardiovascular risk in US adults with nonalcoholic steatohepatitis (NASH) vs. matched non-NASH controls, National Health and Nutrition Examination Survey, 2017–2020

Woolley, J. J., Fishman, J., Parrinello, C. M., & O’Connell, T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309617 · Cited by 6

Advances in fibrosis biomarkers in nonalcoholic fatty liver disease

Ciardullo, S., & Perseghin, G. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.09.003 · Cited by 6

When the liver gets stiff, the tough get moving

Nguyen, T., Wardell, R., Chitturi, S., Teoh, N., & Farrell, G. C. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14963 · Cited by 6

Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery—a Post Hoc Analysis of the FibroTest Prospective Study

Codjia, T., Rebibo, L., François, A., Brasse‐Lagnel, C., Huet, E., Bekri, S., Pattou, F. N., Regimbeau, J., & Schwarz, L. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05402-0 · Cited by 6

Comparing the performance of Fibrosis-4 and Non-Alcoholic Fatty Liver Disease Fibrosis Score with transient elastography scores of people with non-alcoholic fatty liver disease

Cox, B., Trasolini, R. P., Galts, C., Yoshida, E. M., & Marquez, V. (2021) · Canadian Liver Journal · doi:10.3138/canlivj-2021-0004 · Cited by 6

Emerging Circulating Biomarkers for The Diagnosis and Assessment of Treatment Responses in Patients with Hepatic Fat Accumulation, Nash and Liver Fibrosis

Iruarrizaga‐Lejarreta, M., Bril, F., Noureddin, M., Ortiz, P., Lu, S. C.-L., Mato, J. M., & Alonso, C. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_16 · Cited by 6

Assessment of Liver Fibrosis by Transient Elastography in Children and Young Adults With Sickle Cell Disease With and Without Iron Overload

Alvarez, O. A., Cumming, V., & Fifi, A. C. (2022) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002433 · Cited by 5

Non-Invasive Tests for the Detection of MASLD: Biomarkers and Imaging for Staging Steatosis, MASH, and Fibrosis

Wang, L. Y., & Wang, Y. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s593387 · Cited by 5

Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort study

Pustjens, J., Bech, K., Pera, G., van Kleef, L. A., Schnefeld, H. L., de Knegt, R. J., Murad, S. D., Janssen, H. L. A., Andersen, P., Hansen, J. K., et al. (2026) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(26)00091-9 · Cited by 5

Prevalence of non-alcoholic fatty liver disease (NAFLD) in a cohort of patients with type 2 diabetes: the PHIGNA-DM2 study

García‐Luna, P. P., Martínez-Ortega, A. J., Piñar-Gutiérrez, A., Lara, C., Remón-Ruiz, P., Herrojo, J. A., de Lara-Rodríguez, I., Romero‐Gómez, M., & Soto‐Moreno, A. (2022) · Nutrición Hospitalaria · doi:10.20960/nh.03969 · Cited by 5

Circulating microRNAs as potential non-invasive biomarkers for diagnosis and severity assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease: a case–control study

Nafeh, H., Abbas, N. M., El‐Mokhtar, M. A., Hassan, H. M., & Hassany, S. M. (2025) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-025-00511-z · Cited by 4

Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease

Zhao, Y., Leng, S., Wang, Y., Kui, F.-Z., & Gan, W. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i11.110080 · Cited by 4

Expert Panel Consensus on Clinical Assertion Statements Describing Noninvasive Tools for Diagnosing Nonalcoholic Steatohepatitis

Jacobson, I. M., Wong, V. W., Castéra, L., Anstee, Q. M., Noureddin, M., Cusi, K. J., Harrison, S. A., Bugianesi, E., & Younossi, Z. M. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001780 · Cited by 4

Feasibility and acceptability of a primary care liver fibrosis testing pathway centred on the diabetes annual review: PRELUDE1 prospective cohort study protocol

Brindley, J. H., Abeysekera, K. W. M., Hood, G., Jennings, S., Moore, J. W., Hickman, M., & Alazawi, W. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-066493 · Cited by 4

Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities

Aggarwal, K., Singh, B. P., Goel, A., Agrawal, D., Bansal, S., Kanagala, S. G., Anamika, F., Gupta, A., & Jain, R. (2024) · Intestinal Research · doi:10.5217/ir.2024.00001 · Cited by 4

Validation of serum non‐invasive tests of liver fibrosis as prognostic markers of clinical outcomes in people with fatty liver disease in Australia

Vaz, K., Kemp, W. W., Majeed, A., Lubel, J. S., Magliano, D. J., Glenister, K., Bourke, L., Simmons, D. S., & Roberts, S. K. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16774 · Cited by 4

The Relevance of Noninvasive Tools To Assess Fibrosis in Non-Alcoholic Fatty Liver Disease

Pennisi, G., Celsa, C., Giammanco, A., Spatola, F., & Petta, S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200521133307 · Cited by 4

Impact of 20% Change in Vibration-Controlled Transient Elastography-Measured Liver Stiffness on Liver-Related Outcomes: A Systematic Review and Meta-Analysis

Ouranos, K., Michael, M., Mylona, E. K., Shehadeh, F., Kalligeros, M., Teng, M. L. P., Muthiah, M. D., Siddiqui, M. S., Kodali, S., Basra, T., et al. (2026) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.12.021 · Cited by 3

Factors associated with discordance in the assessment of fibrosis stage between transient elastography and liver biopsy in NAFLD patients

Lu, M., Zhu, M., Li, H., Wang, Q., Qian, Y., Wang, M., & Chen, L. (2023) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2023.102183 · Cited by 3

Evaluation of Hepatic Steatosis and Fibrosis Using Transient Elastography in Patients With Obstructive Sleep Apnea

Parchani, A., Gupta, R. M., Kant, R., Saini, L. K., & Gupta, R. K. (2023) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2023.09.010 · Cited by 3

Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease

Ahmed, M., Saeed, R., Kamani, L., Durrani, N., & Ahmed, F. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1789_23 · Cited by 3

Hepatocyte uptake ratio derived from T1 mapping for quantitative assessment of liver fibrosis

Zhang, G., Li, M., Feng, H., Ren, Y., Jin, X. S., Ke, Q., Li, J., Zhou, Y., Chan, Q., Qin, S., et al. (2025) · European Radiology · doi:10.1007/s00330-025-11842-4 · Cited by 3

Multidisciplinary Approach for Liver Transplantation in Patients with Nonalcoholic Steatohepatitis: It Takes a Village

Tsai, E., Patnaik, R., & Alkhouri, N. (2020) · Digestive Disease Interventions · doi:10.1055/s-0040-1705103 · Cited by 3

Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European Survey

Anstee, Q. M., Hallsworth, K., Lynch, N., Hauvespre, A., Mansour, E., Kozma, S., Bottomley, J., Milligan, G., Piercy, J., & Higgins, V. (2023) · Pragmatic and Observational Research · doi:10.2147/por.s392320 · Cited by 3

Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver Disorder

Barazesh, M., Jalili, S., Akhzari, M., Faraji, F., & Khorramdin, E. (2023) · Current Drug Therapy · doi:10.2174/1574885518666230417111247 · Cited by 3

Plasma Circulating Metabolites Associated With Steatotic Liver Disease and Liver Enzymes: A Multiplatform Population-Based Study

Abozaid, Y. J., Ayada, I., van Kleef, L. A., Goulding, N., Williams-Nguyen, J. S., Kaplan, R. C., de Knegt, R. J., Wagenknecht, L. E., Palmer, N. D., Timpson, N. J., et al. (2024) · Gastro Hep Advances · doi:10.1016/j.gastha.2024.09.006 · Cited by 4

Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease

Cho, Y. (2024) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2024.103 · Cited by 3

Liver Fibrosis Assessment in Chronic Liver Diseases Using Elastography: A Comprehensive Review of Vibration-Controlled Transient Elastography and Shear Wave Elastography

Lee, H. A. (2024) · Clinical Ultrasound · doi:10.18525/cu.2024.9.2.70 · Cited by 3

The Use of Non-invasive Biomarkers to Screen for Advanced Fibrosis Associated with Metabolic Dysfunction-associated Steatotic Liver Disease in People with Type 2 Diabetes: A Narrative Review

Williams, D. M., Nagaraj, J., Stephens, J. W., & Min, T. (2025) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2025.21.1.4 · Cited by 3

Diagnostic Performance of Noninvasive Methods for Liver Biopsy by Fibroscan in Pediatric

Motamed, F., Heidari, G., Heirati, B., & Rahmani, P. (2021) · Journal of Child Science · doi:10.1055/s-0041-1725079 · Cited by 3

Does NAFLD Fibrosis Score predict mortality risk among MAFLD patients?: a systematic review and meta-analysis

Rahadini, A. A. D., & Rahadina, A. (2021) · Bali Medical Journal · doi:10.15562/bmj.v10i2.2359 · Cited by 3

Noninvasive diagnosis of liver fibrosis in NAFLD: Tips tricks

Zuberbuhler, F., & Boursier, J. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.03.009 · Cited by 3

Can liver stiffness measurement accurately predict disease progression and clinical outcome in patients with metabolic dysfunction-associated steatotic liver disease and bridging fibrosis or cirrhosis?

van Doorn, D. J., Holleboom, A. G., Takkenberg, R. B., Verheij, J., & Lantinga, M. A. (2023) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-23-445 · Cited by 2

Biomarcadores séricos para la evaluación de la fibrosis hepática

Maroto‐García, J., Moreno‐Álvarez, A., de Pedro, M. P. S., Soto, A. B., & González, Á. (2024) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2023-0172 · Cited by 2

A Prediction Nomogram of Severe Obstructive Sleep Apnea in Patients with Obesity Based on the Liver Stiffness and Abdominal Visceral Adipose Tissue Quantification

Zhao, A., Hao, B., Liu, S., Qiu, X., Ming, X., Yang, X., Cai, J., Li, Z., & Chen, X. (2024) · Nature and Science of Sleep · doi:10.2147/nss.s475534 · Cited by 2

Influence of levothyroxine replacement on metabolic dysfunction-associated steatotic liver disease and dyslipidemia in subclinical hypothyroidism: insights from a randomized controlled study

Mahran, Z. G., Osman, S. M., Abdelmawgod, A., Makhlouf, N. A., Hassan, E. A., & Moustafa, E. F. (2025) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-025-00415-y · Cited by 2

Nichtinvasive Diagnostik bei nichtalkoholischer Fettlebererkrankung (NAFLD)

Stauber, R. E. (2019) · Journal für Gastroenterologische und Hepatologische Erkrankungen · doi:10.1007/s41971-019-00058-1 · Cited by 2

Fibrofast and Fibrosis-4 versus Fibroscan as Indicators of Hepatic Fibrosis in Non Alcholic Fatty Liver Disease Patients: A Cross-Sectional Study

Badawi, R., Hussein, B. E.-S., Watany, M. M., Elsabagh, H. M., & Elkhalawany, W. A. (2022) · african journal of gastroenterology and hepatology · doi:10.21608/ajgh.2022.153872.1010 · Cited by 2

“NASH-Worldwide the Commonest Aetiology of Liver Cirrhosis”- a Review Article

Jannat, S. N. E., Islam, M. M. S. U., Haque, M. M., Imam, I., & Ahmed, D. S. (2023) · Bangabandhu Sheikh Mujib Medical College Journal · doi:10.3329/bsmmcj.v2i2.69844 · Cited by 2

Integrating the applicability rate into the performance evaluation of noninvasive staging of liver fibrosis: A step towards a change from the “accuracy” to the “clinical” paradigm

Carrat, F. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.10.004 · Cited by 1

P.139 An international external quality assessment scheme for hepatitis C virus genotyping

Read, S., Best, S. J., & Jardine, D. K. (2006) · Journal of Clinical Virology · doi:10.1016/s1386-6532(06)80319-7

P.138 Evaluation of a new, non-invasive marker for fibrosis (FIB-4) in a large series of patients infected by the hepatitis C virus alone

Vallet‐Pichard, A., Nalpas, A., Nalpas, B., Serpaggi, J., Varaut, A., Fontaine, H., & Pol, S. (2006) · Journal of Clinical Virology · doi:10.1016/s1386-6532(06)80318-5

Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.

Staufer, K., Halilbasic, E., Spindelboeck, W., Eilenberg, M., Prager, G., Stadlbauer, V., Posch, A., Munda, P., Marculescu, R., Obermayer-Pietsch, B. M., et al. (2019) · Open Access CRIS of the University of Bern · doi:10.7892/boris.139446

Comparison of blood tests for liver fibrosis specific or not to NAFLD

Calès, P., Lainé, F., Boursier, J., Deugnier, Y., Moal, V., Oberti, F., Hunault, G., Rousselet, M. C., Hubert, I., Laafi, J., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.035 · Cited by 255